ArticleBioengineering & translational medicine2023

Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumor.

Ruihan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.